Composition:

Rosuvaling plus 5 mg/10 mg: Rosuvastatin 5 + 10 mg Ezetimibe
 
Rosuvaling plus 10 mg/10 mg: Rosuvastatin 10 mg +10 mg Ezetimibe 
 
Rosuvaling plus 20 mg/10 mg: Rosuvastatin 20 mg +10 mg Ezetimibe 

Therapeutic indications: 
 Rosuvaling Plus is indicated as an adjunct to diet for the treatment of primary hypercholesterolemiaas substitution therapy in adult patients adequately controlled with the individual substances given concurrently at the same dose level as in the fixed combination medicinal products, but as separate products.